^
    CANCER:

    Merkel Cell Carcinoma





    Show legend
    Group by Gene:
    Include preclinical:

    nivolumab
    		0
    PD1 inhibitor
    retifanlimab-dlwr
    pembrolizumab
    1
    PD-L1 inhibitor
    avelumab
    2
    Topoisomerase II inhibitor, DNA inhibitor, DNA synthesis inhibitor
    cisplatin + etoposide oral
    3
    DNA synthesis inhibitor
    cisplatin
    4
    Tubulin polymerization promoter
    carboplatin
    5
    Topoisomerase I inhibitor
    topotecan
    6
    Multi-tyrosine kinase inhibitor
    pazopanib
    7
    GM-CSF agonist
    talimogene laherparepvec
    8
    PD1 inhibitor, CTLA4 inhibitor
    nivolumab + ipilimumab
    9
    CTLA4 inhibitor
    ipilimumab
    10
    TLR9 agonist
    AST-008
    11
    Immunostimulant
    ITI-3000
    12
    MDM2 inhibitor
    KRT-232
    RAIN-32
    13
    Immunotherapy
    Immunotherapy
    14
    Chemotherapy
    CAV
    EP
    15
    Topoisomerase II inhibitor, Tubulin polymerization promoter, DNA inhibitor
    carboplatin + etoposide oral
    16
    DLL3-targeted antibody-drug conjugate, DNA replication inhibitor
    rovalpituzumab tesirine
    17
    CD56-targeted antibody-drug conjugate, Microtubule inhibitor
    McSAF 03
    No biomarker
    PD-L1 negative
    PD-L1 expression
    NTRK1 mutation
    PD-1 expression
    TP53 wild-type
    DLL3 expression
    NCAM1 expression
    NKX2-1 expression
    ARID2 mutation